Annual ROE
-66.06%
-15.66%-31.07%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual return on equity is -66.06%, with the most recent change of -15.66% (-31.07%) on December 31, 2023.
- During the last 3 years, CRMD annual ROE has fallen by -1.15% (-1.77%).
- CRMD annual ROE is now -106.55% below its all-time high of 1007.96%, reached on December 31, 2012.
Performance
CRMD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-72.96%
+13.66%+15.77%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly return on equity is -72.96%, with the most recent change of +13.66% (+15.77%) on September 30, 2024.
- Over the past year, CRMD quarterly ROE has increased by +1.45% (+1.95%).
- CRMD quarterly ROE is now -100.93% below its all-time high of 7830.23%, reached on December 31, 2012.
Performance
CRMD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CRMD ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.1% | +1.9% |
| 3 y3 years | -1.8% | -45.3% |
| 5 y5 years | +85.1% | -51.3% |
CRMD ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.1% | at low | -81.8% | +15.8% |
| 5 y | 5-year | -31.1% | +42.5% | -81.8% | +20.1% |
| alltime | all time | -106.5% | +88.3% | -100.9% | +99.4% |
CorMedix ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -72.96%(-15.8%) |
| Jun 2024 | - | -86.62%(+8.4%) |
| Mar 2024 | - | -79.91%(+7.4%) |
| Dec 2023 | -66.06%(+31.1%) | -74.41%(+11.3%) |
| Sep 2023 | - | -66.87%(+0.1%) |
| Jun 2023 | - | -66.83%(+15.4%) |
| Mar 2023 | - | -57.92%(+15.4%) |
| Dec 2022 | -50.40%(-4.4%) | -50.21%(+6.3%) |
| Sep 2022 | - | -47.22%(+0.7%) |
| Jun 2022 | - | -46.88%(+16.8%) |
| Mar 2022 | - | -40.13%(-5.1%) |
| Dec 2021 | -52.72%(-18.8%) | -42.29%(-2.6%) |
| Sep 2021 | - | -43.42%(-10.0%) |
| Jun 2021 | - | -48.23%(-18.9%) |
| Mar 2021 | - | -59.48%(-23.1%) |
| Dec 2020 | -64.91%(-43.6%) | -77.32%(-7.6%) |
| Sep 2020 | - | -83.68%(-8.4%) |
| Jun 2020 | - | -91.37%(+16.2%) |
| Mar 2020 | - | -78.64%(-13.6%) |
| Dec 2019 | -114.99%(-74.0%) | -90.99%(+15.8%) |
| Sep 2019 | - | -78.55%(-75.3%) |
| Jun 2019 | - | -317.43%(-81.5%) |
| Mar 2019 | - | -1719.86%(-263.5%) |
| Dec 2018 | -442.46%(+67.6%) | 1052.08%(-109.3%) |
| Sep 2018 | - | -11.32 K%(+1444.3%) |
| Jun 2018 | - | -733.30%(+81.8%) |
| Mar 2018 | - | -403.43%(+49.3%) |
| Dec 2017 | -264.00% | -270.16%(+44.2%) |
| Sep 2017 | - | -187.30%(+27.3%) |
| Jun 2017 | - | -147.12%(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | -125.91%(+37.8%) |
| Dec 2016 | -95.10%(-1.6%) | -91.40%(+26.9%) |
| Sep 2016 | - | -72.00%(+36.0%) |
| Jun 2016 | - | -52.94%(-8.4%) |
| Mar 2016 | - | -57.81%(-24.7%) |
| Dec 2015 | -96.62%(-82.8%) | -76.75%(-16.4%) |
| Sep 2015 | - | -91.81%(-43.4%) |
| Jun 2015 | - | -162.15%(-59.7%) |
| Mar 2015 | - | -402.40%(-80.9%) |
| Dec 2014 | -562.76%(-347.8%) | -2107.35%(-191.7%) |
| Sep 2014 | - | 2296.93%(+267.9%) |
| Jun 2014 | - | 624.41%(-18.4%) |
| Mar 2014 | - | 765.53%(+117.9%) |
| Dec 2013 | 227.06%(-77.5%) | 351.25%(-10.0%) |
| Sep 2013 | - | 390.22%(-24.5%) |
| Jun 2013 | - | 516.74%(-35.1%) |
| Mar 2013 | - | 796.82%(-89.8%) |
| Dec 2012 | 1007.96%(-301.2%) | 7830.23%(-1461.5%) |
| Sep 2012 | - | -575.10%(-9.5%) |
| Jun 2012 | - | -635.39%(+62.6%) |
| Mar 2012 | - | -390.81%(+56.2%) |
| Dec 2011 | -501.04%(+233.4%) | -250.25%(+16.3%) |
| Sep 2011 | - | -215.21%(+71.7%) |
| Jun 2011 | - | -125.35%(+52.5%) |
| Mar 2011 | - | -82.18%(-31.2%) |
| Dec 2010 | -150.30%(-372.2%) | -119.51%(-68.0%) |
| Sep 2010 | - | -373.50%(-46.6%) |
| Jun 2010 | - | -698.87%(-205.6%) |
| Mar 2010 | - | 661.99%(+1099.0%) |
| Dec 2009 | 55.21% | 55.21% |
FAQ
- What is CorMedix annual return on equity?
- What is the all time high annual ROE for CorMedix?
- What is CorMedix annual ROE year-on-year change?
- What is CorMedix quarterly return on equity?
- What is the all time high quarterly ROE for CorMedix?
- What is CorMedix quarterly ROE year-on-year change?
What is CorMedix annual return on equity?
The current annual ROE of CRMD is -66.06%
What is the all time high annual ROE for CorMedix?
CorMedix all-time high annual return on equity is 1007.96%
What is CorMedix annual ROE year-on-year change?
Over the past year, CRMD annual return on equity has changed by -15.66% (-31.07%)
What is CorMedix quarterly return on equity?
The current quarterly ROE of CRMD is -72.96%
What is the all time high quarterly ROE for CorMedix?
CorMedix all-time high quarterly return on equity is 7830.23%
What is CorMedix quarterly ROE year-on-year change?
Over the past year, CRMD quarterly return on equity has changed by +1.45% (+1.95%)